Upgrade to SI Premium - Free Trial

TransCode Therapeutics (RNAZ)

1.60 -0.05 (3.03%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/17/25 *Est.)

Latest Headlines

Form 4 Transcode Therapeutics, For: Sep 09 Filed by: Fitzgerald Thomas A September 11, 2026 5:10 PM - SEC Filing Form 8-K Transcode Therapeutics, For: Sep 09 September 11, 2026 5:01 PM - SEC Filing TransCode Therapeutics CFO Tom Fitzgerald retires, replaced interim September 10, 2026 4:13 PM - StreetInsider TransCode Therapeutics Announces Leadership Transition September 10, 2026 4:10 PM - PR NewsWire Join TransCode Therapeutics' Live Investor Webinar: Advancing a Multi-Platform Oncology Pipeline Targeting Metastatic Cancer September 3, 2026 9:00 AM - StreetInsider Form 10-Q Transcode Therapeutics, For: Jun 30 August 14, 2026 5:06 PM - SEC Filing Virax Biolabs and Transcode Therapeutics Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV August 7, 2026 9:01 AM - StreetInsider Form 4 Transcode Therapeutics, For: Aug 03 Filed by: CK Life Sciences Intl (Holdings) Inc August 5, 2026 4:06 PM - SEC Filing Form 3 Transcode Therapeutics, For: Jul 27 Filed by: CK Life Sciences Intl (Holdings) Inc August 5, 2026 4:06 PM - SEC Filing Form SCHEDULE 13D/A Transcode Therapeutics, Filed by: CK Life Sciences Intl (Holdings) Inc August 3, 2026 4:39 PM - SEC Filing Form 8-K Transcode Therapeutics, For: Aug 03 August 3, 2026 4:16 PM - SEC Filing Form SCHEDULE 13G Transcode Therapeutics, Filed by: Unleash Immuno Oncolytics, Inc. July 28, 2026 7:52 PM - SEC Filing Form SCHEDULE 13G Transcode Therapeutics, Filed by: Braci Elena Rosa July 28, 2026 7:51 PM - SEC Filing Form SCHEDULE 13G Transcode Therapeutics, Filed by: Katzman Daniel Eduardo July 28, 2026 7:49 PM - SEC Filing Form SCHEDULE 13D/A Transcode Therapeutics, Filed by: CK Life Sciences Intl (Holdings) Inc July 27, 2026 4:15 PM - SEC Filing Form SCHEDULE 13D/A Transcode Therapeutics, Filed by: CK Life Sciences Intl (Holdings) Inc July 23, 2026 4:15 PM - SEC Filing Form 424B3 Transcode Therapeutics, July 20, 2026 5:07 PM - SEC Filing Form 424B3 Transcode Therapeutics, July 20, 2026 5:05 PM - SEC Filing Form 8-K Transcode Therapeutics, For: Jul 20 July 20, 2026 4:15 PM - SEC Filing Form SCHEDULE 13D/A Transcode Therapeutics, Filed by: CK Life Sciences Intl (Holdings) Inc July 17, 2026 4:16 PM - SEC Filing Form DEFA14A Transcode Therapeutics, July 17, 2026 4:08 PM - SEC Filing Form 8-K Transcode Therapeutics, For: Jul 16 July 17, 2026 4:06 PM - SEC Filing Form 8-K Transcode Therapeutics, For: Jul 02 July 2, 2026 4:06 PM - SEC Filing Form 8-K Transcode Therapeutics, For: Jun 18 June 18, 2026 8:01 AM - SEC Filing Full Article List